169 related articles for article (PubMed ID: 10389572)
1. Unsuccessful treatment of pulmonary hypertension by inhaled nitric oxide and aerosolized prostacyclin.
Tibballs J; Goh TH; McKenzie I; Hochmann M
Anaesth Intensive Care; 1999 Jun; 27(3):316-7. PubMed ID: 10389572
[No Abstract] [Full Text] [Related]
2. Unsuccessful treatment of pulmonary hypertension by inhaled nitric oxide and aerosolized prostacyclin.
Barry PW
Anaesth Intensive Care; 1999 Dec; 27(6):670-1. PubMed ID: 10631434
[No Abstract] [Full Text] [Related]
3. [Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis].
Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbrück B; Grimminger F; Seeger W
Pneumologie; 2000 Mar; 54(3):133-42. PubMed ID: 10783653
[TBL] [Abstract][Full Text] [Related]
4. Comparison of inhaled nitric oxide and inhaled aerosolized prostacyclin in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance.
Haraldsson A; Kieler-Jensen N; Nathorst-Westfelt U; Bergh CH; Ricksten SE
Chest; 1998 Sep; 114(3):780-6. PubMed ID: 9743166
[TBL] [Abstract][Full Text] [Related]
5. Effects of inhaled versus intravenous vasodilators in experimental pulmonary hypertension.
Walmrath D; Schermuly R; Pilch J; Grimminger F; Seeger W
Eur Respir J; 1997 May; 10(5):1084-92. PubMed ID: 9163651
[TBL] [Abstract][Full Text] [Related]
6. Effect of aerosolized prostacyclin and inhaled nitric oxide on experimental hypoxic pulmonary hypertension.
Max M; Kuhlen R; Dembinski R; Rossaint R
Intensive Care Med; 1999 Oct; 25(10):1147-54. PubMed ID: 10551974
[TBL] [Abstract][Full Text] [Related]
7. Inhaled aerosolized prostacyclin and nitric oxide as selective pulmonary vasodilators in ARDS--a pilot study.
Van Heerden PV; Blythe D; Webb SA
Anaesth Intensive Care; 1996 Oct; 24(5):564-8. PubMed ID: 8909667
[TBL] [Abstract][Full Text] [Related]
8. Re: Delivery of inhaled aerosolized prostacyclin (IAP).
van Heerden PV; Power BM; Leonard RC
Anaesth Intensive Care; 1996 Oct; 24(5):624-5. PubMed ID: 8909691
[No Abstract] [Full Text] [Related]
9. Intravenous prostacyclin mitigates inhaled nitric oxide rebound effect: A case control study.
Hermon M; Golej J; Burda G; Marx M; Trittenwein G; Pollak A
Artif Organs; 1999 Nov; 23(11):975-8. PubMed ID: 10564300
[TBL] [Abstract][Full Text] [Related]
10. Acute effect of oral prostacyclin and inhaled nitric oxide on pulmonary hypertension in children.
Ichida F; Uese K; Hashimoto I; Hamamichi Y; Tsubata S; Fukahara K; Murakami A; Miyawaki T
J Cardiol; 1997 Apr; 29(4):217-24. PubMed ID: 9127838
[TBL] [Abstract][Full Text] [Related]
11. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
Kieler-Jensen N; Lundin S; Ricksten SE
J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
[TBL] [Abstract][Full Text] [Related]
12. Aerosolized prostacyclin versus inhaled nitric oxide in children with severe acute respiratory distress syndrome.
Pappert D; Busch T; Gerlach H; Lewandowski K; Radermacher P; Rossaint R
Anesthesiology; 1995 Jun; 82(6):1507-11. PubMed ID: 7793662
[No Abstract] [Full Text] [Related]
13. Vasodilators in the treatment of primary pulmonary hypertension.
Weir EK; Schremmer B
Eur Respir J; 1998 Aug; 12(2):263-4. PubMed ID: 9727771
[No Abstract] [Full Text] [Related]
14. [Aerosolized prostacyclin for preoperative evaluation and post-cardiosurgical treatment of patients with pulmonary hypertension].
Schulze-Neick I; Uhlemann F; Nürnberg JH; Bültmann M; Haas NA; Dähnert I; Alexi-Meshkishvili V; Opitz C; Pappert D; Rossaint R; Kleber FX; Hetzer R; Lange PE
Z Kardiol; 1997 Feb; 86(2):71-80. PubMed ID: 9173700
[TBL] [Abstract][Full Text] [Related]
15. Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis.
Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbruck B; Grimminger F; Seeger W
Am J Respir Crit Care Med; 1999 Aug; 160(2):600-7. PubMed ID: 10430735
[TBL] [Abstract][Full Text] [Related]
16. Aerosolized prostacyclin and inhaled nitric oxide in septic shock--different effects on splanchnic oxygenation?
Eichelbrönner O; Reinelt H; Wiedeck H; Mezödy M; Rossaint R; Georgieff M; Radermacher P
Intensive Care Med; 1996 Sep; 22(9):880-7. PubMed ID: 8905421
[TBL] [Abstract][Full Text] [Related]
17. Nebulized prostacyclin for pulmonary hypertension: a step in the right direction.
Wang A; Bashore TM
Eur Heart J; 1997 Sep; 18(9):1364-5. PubMed ID: 9458437
[No Abstract] [Full Text] [Related]
18. Combined therapy with inhaled nitric oxide and intravenous vasodilators during acute and chronic experimental pulmonary hypertension.
Aranda M; Bradford KK; Pearl RG
Anesth Analg; 1999 Jul; 89(1):152-8. PubMed ID: 10389795
[TBL] [Abstract][Full Text] [Related]
19. Inhaled nitric oxide in children with pulmonary hypertension and congenital mitral stenosis.
Atz AM; Adatia I; Jonas RA; Wessel DL
Am J Cardiol; 1996 Feb; 77(4):316-9. PubMed ID: 8607419
[TBL] [Abstract][Full Text] [Related]
20. The perioperative management of portopulmonary hypertension with nitric oxide and epoprostenol.
Ramsay MA; Spikes C; East CA; Lynch K; Hein HA; Ramsay KJ; Klintmalm GB
Anesthesiology; 1999 Jan; 90(1):299-301. PubMed ID: 9915339
[No Abstract] [Full Text] [Related]
[Next] [New Search]
